The Journal of Pharmacology and Experimental Therapeutics issued an Expression of Concern in 2021 (PMID: 34551989) for the McCoy et al
Preparation for July 2026 PCAC Meeting MOTs-C Regulatory Sarah Taylor, PharmD July 16, 2026 Ketamine Uses Clinical Insights Kerry Earlywine April 29, 2026 Glutathione: A Review on Dosing via Various Routes of Administration Anti-aging Sarah Taylor, PharmD April 13, 2026 How to Choose an Active Pharmaceutical Ingredient for Bulk Compounding Compounding Fundamentals Sarah Taylor, PharmD March 16, 2026 GHK-Cu: Beyond Cosmetic Hype Alopecia Sarah Taylor, PharmD February 11, 2026 Topical Management of Hirsutism Dermatology Sarah Taylor, PharmD January 7, 2026 Azelastine HCl An Update ENT Sarah Taylor, PharmD December 4, 2025 Intracavernosal Injections for Erectile Dysfunction: The Basics Erectile Dysfunction Sarah Taylor, PharmD October 30, 2025 Antiparasitic Agents and Emerging Data on Their Utility as a Cancer Treatment Oncology Sarah Taylor, PharmD September 26, 2025 Next [email protected] 1301 Corporate Center Drive Suite 112, Eagan, MN 55121 FacultyTestimonialsCareersContact Membership PlansFACTSEventsContinued Education 2014-2023 Fagron Academy
The vial contains 20 such portions
Patients with severe hepatic or renal impairment may require special consideration, though specific dosing guidelines for these populations have not been established
